IMAC Holdings Receives Notification of Deficiency From Nasdaq Related to Delayed Filing of Quarterly Report on Form 10-Q
IMAC Holdings Receives Notification of Deficiency From Nasdaq Related to Delayed Filing of Quarterly Report on Form 10-Q
FRANKLIN, TN, Nov. 22, 2024 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. ("IMAC" or the "Company") (NASDAQ: BACK) today announced that it received an expected deficiency notification letter from the Listing Qualifications Staff of The Nasdaq Stock Market LLC ("Nasdaq") on November 22, 2024 (the "Notice"). The Notice indicated that the Company was not in compliance with Nasdaq Listing Rule 5250(c)(1) (the "Listing Rule") as a result of its failure to timely file its Quarterly Report on Form 10-Q for the period ended September 30, 2024 (the "Form 10-Q"), as described more fully in the Company's Form 12b-25 Notification of Late Filing (the "Form 12b-25") filed with the Securities and Exchange Commission (the "SEC") on November 15, 2024. The Listing Rule requires Nasdaq-listed companies to timely file all required periodic reports with the SEC.
田納西州法蘭克林市,2024年11月22日(全球新聞通訊)-- IMAC控股公司("IMAC"或"公司")(納斯達克:BACK)今天宣佈,它於2024年11月22日收到了來自納斯達克股票市場有限責任公司("納斯達克")上市資格工作人員的預期缺陷通知函("通知")。該通知指出,公司未能遵守納斯達克上市規則5250(c)(1)("上市規則"),原因是未能及時提交截至2024年9月30日的10-Q季度報告("10-Q表格"),這一情況在公司於2024年11月15日向證券交易委員會("SEC")提交的120億.25表格的逾期通知中有更詳細的說明("120億.25表格")。上市規則要求納斯達克上市公司及時向SEC提交所有所需的定期報告。
The Company continues to work diligently to file the Form 10-Q as soon as practicable.
公司繼續努力盡快提交表10-Q。
The Notice has no immediate effect on the listing or trading of the Company's common stock on the Nasdaq Capital Market.
通知對公司普通股在納斯達克資本市場上的上市或交易沒有立即影響。
The Company has until January 21, 2024, to submit a plan to regain compliance with the Listing Rule (the "Plan"). Pursuant to the Notice, if Nasdaq accepts the Plan, Nasdaq has the discretion to grant the Company an exception of up to 180 calendar days from the due date of the Form 10-Q, or until May 19, 2025, to regain compliance with the Listing Rule. The Company intends to take the necessary steps to regain compliance with Nasdaq's listing rules as soon as practicable.
公司有直到2024年1月21日的時間提交一個計劃以重新符合上市規則("計劃")。根據通知,如果納斯達克接受該計劃,納斯達克有權根據情況給予公司最多180個日曆天的例外時間,從10-Q表格的到期日算起,或直到2025年5月19日,以重新符合上市規則。公司打算儘快採取必要措施以重新符合納斯達克的上市規則。
While the Company can provide no assurances as to timing, the Company intends to take action to submit a plan to regain compliance within the 60 calendar day submission period, and, if Nasdaq accepts the plan to regain compliance, to subsequently regain compliance within the extended time granted by Nasdaq. While the Company is exercising diligent efforts to maintain the listing of its securities on the Nasdaq Capital Market, there can be no assurance that the Company will be able to regain compliance within the applicable time period. In addition, if the Company does not regain compliance within the applicable time period, Nasdaq could provide notice that the Company's securities will become subject to delisting. If the Company receives notice that its securities are being delisted, Nasdaq rules permit the Company to appeal any delisting determination by Nasdaq staff to a hearings panel.
雖然公司不能保證時間,但公司打算在60個日曆天的提交期內採取行動並提交計劃以恢復合規性,如果納斯達克接受恢復合規性的計劃,公司將在納斯達克授予的延長時間內恢復合規性。儘管公司正在努力維護納斯達克資本市場上證券的上市地位,但不能保證公司能夠在適用的時間範圍內恢復合規性。此外,如果在適用的時間範圍內未能恢復合規性,納斯達克可能會通知公司的證券將被除牌。如果公司收到證券將被除牌的通知,納斯達克規則允許公司對納斯達克工作人員的除牌決定提起上訴至聽證會。
About IMAC Holdings, Inc.
關於IMAC Holdings, Inc.(IMAC控股公司)。
IMAC Holdings, Inc. is headquartered in Franklin, Tennessee. We operate our proteomic business through our nationally CLIA-certified, CAP-accredited and NY CLEP certified laboratory in Golden, Colorado.
IMAC Holdings, Inc.總部位於田納西州富蘭克林。我們通過我們在科羅拉多州金色的全國CLIA認證、CAP認可和NYCLEP認證實驗室來開展我們的蛋白質組學業務。
Safe Harbor Statement
Safe Harbor聲明
This document and the exhibits contain forward-looking statements within the meaning of Section 21E of the Exchange Act of 1934, as amended, which are made pursuant to the safe harbor provisions of the Securities Litigation Reform Act of 1995, including, but not limited to, statements regarding the timing and expectations regarding the Company's filing of the Form 10-Q, statements relating to the Company's plan to regain compliance with Nasdaq's listing rules, as well as all statements that are not historical facts. These forward-looking statements are subject to change, and actual results may materially differ from those set forth in this Current Report due to certain risks and uncertainties. Factors that could cause or contribute to changes in such forward-looking statements include, but are not limited to, the risk that the completion and filing of the Form 10-Q will take longer than expected; uncertainties about the timing of the Company's submission of a compliance plan; Nasdaq's acceptance of any such plan; the duration of any extension that may be granted by Nasdaq; and the risk that the Company will be unable to meet Nasdaq's continued listing requirements. The foregoing review of important factors should not be construed as exhaustive and should be read in conjunction with the other cautionary statements set forth in reports filed with the SEC, including the Company's current reports on Form 8-K, quarterly reports on Form 10-Q and its annual report on Form 10-K/A, such as statements regarding changes in economic conditions and the impact of competition. Undue reliance should not be placed on any forward-looking statement contained herein. These statements reflect the Company's position as of the date of this Current Report. The Company expressly disclaims any undertaking to release publicly any updates or revisions to any statements to reflect any change in the Company's expectations or any change of events, conditions, or circumstances on which any such statement is based.
本文件及附件包含根據《證券交易法》第21E條(經修訂)的安全港條款於1995年股票訴訟改革法案的適用提出的前瞻性聲明,包括但不限於關於公司提交10-Q表格的時間和預期的聲明,關於公司計劃恢復納斯達克上市規則合規性的聲明,以及所有非歷史事實的陳述。這些前瞻性聲明可能會發生變化,實際結果可能與本當前報告中的情況有實質不同,因爲存在某些風險和不確定性。可能導致此類前瞻性聲明發生變化的因素包括但不限於完成和提交10-Q表格的時間超過預期的風險;關於公司提交合規計劃的時間的不確定性;納斯達克對任何此類計劃的接受;納斯達克可能授予的任何延長期的持續時間;以及公司無法滿足納斯達克的繼續上市要求的風險。對於此處包含的任何前瞻性聲明都不應給予過度依賴,並應與提交給證監會的報告中的其他警示性陳述一起閱讀,包括公司在Form 8-K上的報告、Form 10-Q的季度報告和Form 10-K/A的年度報告,例如關於經濟狀況變化和競爭影響的陳述。不應對此處包含的任何前瞻性聲明作出任何更新或修訂的任何聲明,以反映公司期望的任何變化或與任何適用的事件、情況或情況相關的任何變化。
For additional information, please contact:
有關更多信息,請聯繫:
Investors@imacholdings.com
投資者@imacholdings.com
譯文內容由第三人軟體翻譯。